Nali Ma

Title: Nali Ma: Innovator in Transplant Rejection Evaluation

Introduction

Nali Ma is an accomplished inventor based in Winchester, MA (US), known for his significant contributions to the field of transplant medicine. His innovative work focuses on the evaluation of transplant rejection, which is crucial for improving patient outcomes in organ transplantation.

Latest Patents

Nali Ma holds a patent for the invention titled "Measurement of protective genes in allograft rejection." This invention relates to methods of evaluating transplant rejection in a host by determining a heightened magnitude of gene expression of genes in rejection-associated gene clusters. The disclosed gene clusters include genes that are substantially co-expressed with cytotoxic lymphocyte pro-apoptotic genes, cytoprotective genes, and several other cytokine and immune cell genes. This patent represents a significant advancement in understanding and managing transplant rejection.

Career Highlights

Throughout his career, Nali Ma has worked with prestigious institutions, including Beth Israel Deaconess Medical Center, Inc. and Cornell Research Foundation Inc. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Nali Ma has collaborated with notable colleagues, including Yingyos Avihingsanon and Terry Barton Strom. These collaborations have further enriched his research and have played a vital role in advancing the understanding of transplant rejection mechanisms.

Conclusion

Nali Ma's innovative work in the evaluation of transplant rejection through gene expression analysis has the potential to transform the field of organ transplantation. His contributions are invaluable in improving patient care and outcomes in this critical area of medicine.